Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Howard I Hurtig

Showing results (31-40 of 57) with videos related to

Pageof 6
Sort By:
Movement Disorders : Official Journal of the Movement Disorder Society|February 21, 2012
Genetic influences on cognitive decline in Parkinson's diseaseJames F Morley, Sharon X Xie, Howard I Hurtig, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|September 30, 2010
A recommended scale for cognitive screening in clinical trials of Parkinson's diseaseKelvin L Chou, Melissa M Amick, Jason Brandt, et al.
Stereotactic and Functional Neurosurgery|October 26, 2006
Long-term outcomes of bilateral subthalamic nucleus stimulation in patients with advanced Parkinson's diseaseGrace S Liang, Kelvin L Chou, Gordon H Baltuch, et al.
Alzheimer'S Research & Therapy|November 11, 2017
Circulating brain-enriched microRNAs as novel biomarkers for detection and differentiation of neurodegenerative diseasesKira S Sheinerman, Jon B Toledo, Vladimir G Tsivinsky, et al.
Archives of Neurology|November 14, 2007
Distinct antemortem profiles in patients with pathologically defined frontotemporal dementiaMurray Grossman, David J Libon, Mark S Forman, et al.
Acta Neuropathologica|July 24, 2010
Biomarker discovery for Alzheimer's disease, frontotemporal lobar degeneration, and Parkinson's diseaseWilliam T Hu, Alice Chen-Plotkin, Steven E Arnold, et al.
Annals of Neurology|October 6, 2012
Neuropathologic substrates of Parkinson disease dementiaDavid J Irwin, Matthew T White, Jon B Toledo, et al.
Plos One|May 26, 2017
Regional brain amyloid-β accumulation associates with domain-specific cognitive performance in Parkinson disease without dementiaRizwan S Akhtar, Sharon X Xie, Yin J Chen, et al.
JAMA Neurology|May 24, 2013
Clinical and biochemical differences in patients having Parkinson disease with vs without GBA mutationsLama M Chahine, Judy Qiang, Emily Ashbridge, et al.
Acta Neurochirurgica|October 7, 2011
Expanding applications of deep brain stimulation: a potential therapeutic role in obesity and addiction managementCasey H Halpern, Napoleon Torres, Howard I Hurtig, et al.
Pageof 6

Showing results (31-40 of 57) with videos related to

Sort By:
Pageof 6
Movement Disorders : Official Journal of the Movement Disorder Society|February 21, 2012
Genetic influences on cognitive decline in Parkinson's diseaseJames F Morley, Sharon X Xie, Howard I Hurtig, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|September 30, 2010
A recommended scale for cognitive screening in clinical trials of Parkinson's diseaseKelvin L Chou, Melissa M Amick, Jason Brandt, et al.
Stereotactic and Functional Neurosurgery|October 26, 2006
Long-term outcomes of bilateral subthalamic nucleus stimulation in patients with advanced Parkinson's diseaseGrace S Liang, Kelvin L Chou, Gordon H Baltuch, et al.
Alzheimer'S Research & Therapy|November 11, 2017
Circulating brain-enriched microRNAs as novel biomarkers for detection and differentiation of neurodegenerative diseasesKira S Sheinerman, Jon B Toledo, Vladimir G Tsivinsky, et al.
Archives of Neurology|November 14, 2007
Distinct antemortem profiles in patients with pathologically defined frontotemporal dementiaMurray Grossman, David J Libon, Mark S Forman, et al.
Acta Neuropathologica|July 24, 2010
Biomarker discovery for Alzheimer's disease, frontotemporal lobar degeneration, and Parkinson's diseaseWilliam T Hu, Alice Chen-Plotkin, Steven E Arnold, et al.
Annals of Neurology|October 6, 2012
Neuropathologic substrates of Parkinson disease dementiaDavid J Irwin, Matthew T White, Jon B Toledo, et al.
Plos One|May 26, 2017
Regional brain amyloid-β accumulation associates with domain-specific cognitive performance in Parkinson disease without dementiaRizwan S Akhtar, Sharon X Xie, Yin J Chen, et al.
JAMA Neurology|May 24, 2013
Clinical and biochemical differences in patients having Parkinson disease with vs without GBA mutationsLama M Chahine, Judy Qiang, Emily Ashbridge, et al.
Acta Neurochirurgica|October 7, 2011
Expanding applications of deep brain stimulation: a potential therapeutic role in obesity and addiction managementCasey H Halpern, Napoleon Torres, Howard I Hurtig, et al.
Pageof 6